Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

11.1%

3 terminated/withdrawn out of 27 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

11%

3 trials in Phase 3/4

Results Transparency

50%

9 of 18 completed trials have results

Key Signals

1 recruiting9 with results

Enrollment Performance

Analytics

N/A

11(78.6%)

Phase 4

3(21.4%)

14Total

N/A(11)

Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (27)

Showing 20 of 27 trials

NCT07487701Not ApplicableActive Not Recruiting

Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study

Role: lead

NCT07336420Phase 4Enrolling By Invitation

Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine Treatment

Role: lead

NCT07336056Phase 4Active Not Recruiting

Nerivio Efficacy Under High-Frequency Use

Role: lead

NCT07249931Not ApplicableNot Yet Recruiting

Efficacy and Safety of Nerivio for the Management of Amplified Musculoskeletal Pain Syndrome in Pediatric Patients

Role: collaborator

NCT07227194Completed

Machine Learning Assessment of Next-Day Migraine Likelihood

Role: lead

NCT05443659Completed

Real-world Data Analysis of REN Treatment in Adolescence With Migraine

Role: lead

NCT05464069Completed

Safety of Nerivio in Pregnant Women With Migraine

Role: lead

NCT06138756Completed

Acute Treatment of Migraine in Pre-Adolescents: Real-World Analysis of Remote Electrical Neuromodulation (REN)

Role: lead

NCT06023953Completed

Migraine With and Without Aura Characteristics and Response to Remote Electrical Neuromodulation (REN) Treatment

Role: lead

NCT06976723Phase 4Completed

Nerivio Efficacy by Time of Treatment Onset

Role: lead

NCT05310227Not ApplicableWithdrawn

Nerivio Device for Treatment of New Daily Headache Persistence (NDHP)

Role: collaborator

NCT06738056Completed

Nerivio Long-term Usage in Patients With Migraine

Role: lead

NCT03076515Not ApplicableTerminated

Migraine Treatment With Nerivio Migra Neurostimulation Device

Role: lead

NCT06180577Completed

A Survey Study to Assess the Accessibility of the Nerivio Device At School

Role: lead

NCT05760638Completed

Real-World Evidence (RWE) Data Analysis of 1-year Consecutive Use of Remote Electrical Neuromodulation (REN)

Role: lead

NCT05523310Suspended

Observational Study to Assess Migraine Prediction Tool

Role: lead

NCT05769322Completed

Real World Data Analysis: Impact of High-Frequency REN Treatments As Migraine Preventive Therapy in Adolescence

Role: lead

NCT04992897Completed

Real-world Data Analysis of REN Treatment in Migraine Patients

Role: lead

NCT05940870Completed

A Prospective Post-marketing Observational Study Assessing the Safety and Efficacy of Nerivio for Migraine Prevention.

Role: lead

NCT06271746Not ApplicableRecruiting

Treatment of Fibromyalgia With the FibroNova Neuromodulation Device

Role: lead